Discover the full insider trade history of Q/c Technologies, INC., a listed equity based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Operating in the Technology sector, Q/c Technologies, INC. has published 2 reports. Market capitalisation: €30.7m. The latest transaction was disclosed on 14 May 2026 — Acquisition. Among the most active insiders: Voss Chelsea Sierra. All data is openly available.
0 of 0 declarations
Q/C Technologies, Inc. (Nasdaq Capital Market: QCLS) is a U.S.-listed company headquartered in New York, NY, United States. The business was previously known as TNF Pharmaceuticals, Inc. and formally adopted the Q/C Technologies name and QCLS ticker in September 2025, signaling a strategic pivot away from its legacy biotech identity and toward energy-efficient photonic/laser-based computing infrastructure. For investors, QCLS should be viewed as a very small-cap U.S. transformation story rather than a mature operating company with diversified and stable revenue streams. The company now describes itself as pioneering the next generation of energy-efficient blockchain infrastructure. Its current investment narrative centers on a licensing agreement with LightSolver that gives Q/C exclusive rights to use quantum-inspired laser processing units, or LPUs, for high-performance computing applications. Management’s public messaging emphasizes that these systems are designed to solve compute-intensive combinatorial and physical problems at the speed of light, with the broader goal of reducing power consumption and improving performance and sustainability for blockchain and cryptocurrency-related workloads. The company’s roots matter as well: Q/C Technologies emerged from an earlier pharmaceutical platform, and it has stated that it continues to evaluate strategic options for its legacy therapeutic programs, including isomyosamine and Supera-CBD, while it reallocates attention toward next-generation computing. That legacy creates a nuanced profile: QCLS is not a pure-play semiconductor or software company, but a corporate turnaround with remnants of a biopharma history and a new technology thesis layered on top. Competitive positioning is therefore highly dependent on execution, intellectual property rights, and the credibility of the commercialization pathway, rather than on scale, installed base, or recurring operating momentum. In the broader market, Q/C competes conceptually with large semiconductor, cloud, blockchain infrastructure, and quantum-computing names, but its niche is narrower: a first-mover claim around light-speed laser processing for crypto-oriented infrastructure. Geographically, the company is anchored in the United States, with headquarters in New York and transfer-agent operations in Texas, although the technology narrative is international in scope because the licensed platform originates from LightSolver. Recent notable developments include the September 2025 corporate name change, the ticker transition to QCLS on Nasdaq, and continued regulatory activity, including SEC Form 4 insider transaction filings, which indicate active management and ownership reporting. Overall, Q/C Technologies remains a high-risk, story-driven Nasdaq Capital Market name in the United States, best analyzed through the lens of technological optionality, balance-sheet discipline, and milestone execution rather than near-term fundamentals.